Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
04 Jun 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/bioinvent-presents-at-page-2025-a-poster-highlighting-model-informed-early-clinical-d-1035315
27 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/27/3088581/7281/en/XOMA-Royalty-Purchases-Mezagitamab-Royalty-and-Milestone-Rights-Held-by-BioInvent-International-for-up-to-USD-30-Million.html
14 May 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/bioinvent-presents-additional-ctcl-phase-2a-data-for-bi-1808-monotherapy-at-eha-2025-1027655
14 May 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/bioinvent-announces-updated-phase-2a-triple-combination-arm-data-of-bi-1206-rituximab-1027654
05 May 2025
// #N/A
https://www.accessnewswire.com/newsroom/en/biotechnology/bioinvent-to-participate-in-upcoming-investor-conferences-1023514
29 Apr 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/resolutions-at-bioinvents-annual-general-meeting-2025-1021226
ABOUT THIS PAGE
BioInvent is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of MONOCLONAL ANTIBODY PRODUCTION bulk offered by BioInvent